Literature DB >> 9668204

Adenylosuccinate synthetase of the yeast Saccharomyces cerevisiae: purification and properties.

T A Ryzhova1, Y V Andreichuk, V D Domkin.   

Abstract

Adenylosuccinate synthetase (AS-synthetase) was purified from the yeast Saccharomyces cerevisiae. The purification procedure included chromatography on DEAE-cellulose, phosphocellulose, and heparin-agarose. The pH and temperature optima for the enzyme activity (7.0 and 35 degreesC, respectively) and also pH and thermostability of AS-synthetase were determined. The native form of the enzyme exists as a dimer. The Km values for IMP, GTP, and L-aspartate are 1.7, 0.16, and 6.7 mM, respectively. ATP cannot be used instead of substrate GTP, whereas 2'-dGTP and dd-GTP are able to substitute for GTP in the reaction. ITP also can be a substrate as an analog of GTP and as an analog of IMP. Two intermediates of purine nucleotide biosynthesis de novo, 5-amino-4-(N-succinocarboxamide)imidazole ribonucleotide (ASCIR) and 5-amino-4-carbamoyl-imidazole ribonucleotide (ACIR), inhibit AS-synthetase. Hydroxylamine and aspartate analogs also inhibit the enzyme. Effective binding requires a four-carbon-atom chain and unsubstituted amino group; the charge of the beta-carboxy group is not necessary. Comparison of primary structures and substrate specificity of yeast ASCIR- and AS-synthetases suggests independent origin of these proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668204

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  2 in total

1.  Adenylosuccinate synthase from Saccharomyces cerevisiae: homologous overexpression, purification and characterization of the recombinant protein.

Authors:  G Lipps; G Krauss
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

2.  In the quest for new targets for pathogen eradication: the adenylosuccinate synthetase from the bacterium Helicobacter pylori.

Authors:  Ante Bubić; Natalia Mrnjavac; Igor Stuparević; Marta Łyczek; Beata Wielgus-Kutrowska; Agnieszka Bzowska; Marija Luić; Ivana Leščić Ašler
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.